Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Long Term Provisions

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Long Term Provisions History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Long Term Provisions ₹249 Cr₹155 Cr₹123 Cr₹98 Cr₹80 Cr

What is the latest Long Term Provisions ratio of MANKIND PHARMA ?

The latest Long Term Provisions ratio of MANKIND PHARMA is ₹249 Cr based on Mar2026 Consolidated results.
Year Long Term Provisions
Mar2026₹249 Cr
Mar2025₹155 Cr
Mar2024₹123 Cr
Mar2023₹98 Cr
Mar2022₹80 Cr

How is Long Term Provisions of MANKIND PHARMA Trending?

Years Long Term Provisions % Change
Mar2026 ₹249 Cr
60.36
Mar2025 ₹155 Cr
25.94
Mar2024 ₹123 Cr
25.78
Mar2023 ₹98 Cr
22.36
Mar2022 ₹80 Cr -

Compare Long Term Provisions of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹105,108.5 Cr -1.6% 0.9% -4.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr -0.2% -3.2% 12.7% Stock Analytics
DIVIS LABORATORIES ₹251,531.0 Cr 2% 5.3% 57.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,957.0 Cr -2.4% -3.1% 36.4% Stock Analytics
CIPLA ₹111,729.0 Cr 0.6% -2.2% -9.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,335.0 Cr 0.9% 4% -7.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.6%

0.9%

-4.7%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses